前收市價 | 5.20 |
開市 | 5.20 |
買盤 | 0.00 |
賣出價 | 0.00 |
拍板 | 240.00 |
到期日 | 2025-02-21 |
今日波幅 | 5.20 - 5.20 |
合同範圍 | 無 |
成交量 | |
未平倉合約 | 無 |
Labcorp (LH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
LH is expected to perform strongly in both of its segments and will also likely advance in its strategic priorities.
LH is well-placed for long-term success in Cell & Gene Therapy, expanding into the consumer market and international growth through the specialty testing and biopharma business.